Biotech News
Pulmonx to Participate in September Investor Conferences
investors.pulmonx.com2026-05-06 14:58 EST
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at the following investor conferences: Wells Fargo Healthcare